Evidence supporting a physiological role for proANP-(1-30) in the regulation of renal excretion

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 280, Issue 5 49-5, 2001, Pages

  Dietz, John R ^a,b   Scott, Dionne Y ^a   Landon, Carol S ^a   Nazian, Stanley J ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Atrial natriuretic peptide; Guanosine 3 ,5 cyclic monophosphate, cardiac hormones; Volume expansion

Indexed keywords

ANTIBODY; ATRIAL NATRIURETIC FACTOR; CYCLIC GMP;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; KIDNEY BLOOD FLOW; MALE; MEAN ARTERIAL PRESSURE; MICTURITION; NONHUMAN; POTASSIUM EXCRETION; PRIORITY JOURNAL; RAT; SODIUM EXCRETION; URINARY EXCRETION;

EID: 0035026107     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.2001.280.5.r1510     Document Type: Article

References (31)

1. Benjamin BA. Effects of ANF prohormone peptides in conscious primates. Clin Exp Pharmacol Physiol 22: 125-129, 1995.
2. Benjamin BA and Peterson TV. Effect of proANF-(31-67) on sodium excretion in conscious monkeys. Am J Physiol Regulatory Integrative Comp Physiol 269: R1351-R1355, 1995.
3. Brenner BM, Ballermann BJ, Gunning ME, and Zeidel ML. Diverse biological actions of atrial natriuretic peptide. Physiol Rev 70: 665-695, 1990.
4. +-ATPase of the atrial natriuretic peptides. Endocrinology 136: 2033-2039, 1995.
5. Clinkingbeard C, Sessions C, and Shenker Y. The physiological role of atrial natriuretic hormone in the regulation of aldosterone and salt and water metabolism. J Clin Endocrinol Metab 70: 582-589, 1990.
6. DeBold AJ, Borenstein HB, Veress AT, and Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 28: 89-94, 1981.
7. Dietz JR. Release of natriuretic factor from rat heart-lung preparation by atrial distension. Am J Physiol Regulatory Integrative Comp Physiol 247: R1093-R1096, 1984.
8. Dietz JR. Control of atrial natriuretic factor release from a rat heart-lung preparation. Am J Physiol Regulatory Integrative Comp Physiol 252: R498-R502, 1987.
9. Dietz JR, Gower WR, Vesely DL, Nazian SJ, Landon CS, and Skvorak JP. Molecular species of the atrial natriuretic peptide (ANP) prohormone secreted by isolated rat atria. Atrial Natriuretic Peptides: 119-127, 1997.
10. Dietz JR, Nazian SJ, and Vesely DL. Release of ANF, proANF 1-98, and proANF 31-67 from isolated rat atria by atrial distension. Am J Physiol Heart Circ Physiol 260: H1774-H1778, 1991.
11. Dietz JR, Vesely DL, Gower WR, and Nazian SJ. Secretion and renal effects of ANF prohormone peptides. Clin Exp Pharmacol Physiol 22: 115-120, 1995.
12. Dietz JR, Vesely DL, and Nazian SJ. Effect of changes in sodium intake on atrial natriuretic factor (ANF) and peptides derived from the N terminus of the ANF prohormone in the rat. Proc Soc Exp Biol Med 200: 44-48, 1992.
13. Dietz JR, Vesley DL, and Nazian SJ. Possible mechanisms involved in the natriuretic response to atrial natriuretic factor (ANF) and proANF 31-67 in the rat. Clin Exp Pharmacol Physiol 21: 599-606, 1994.
14. Field LJ, Veress AT, Steinhelper ME, Cochrane K, and Sonnenberg H. Kidney function in ANF transgenic mice effect of blood volume expansion. Am J Physiol Regulatory Integrative Comp Physiol 260: R1-R5, 1991.
15. + transport in rabbit inner medullary collecting duct cells. J Clin Invest 89: 1411-1417, 1992.
16. Gunning M, Brenner BM, Otuechere G, and Zeidel ML. ANP 31-67 inhibits transport dependent oxygen consumption (QO2) in inner medullary collecting duct (IMCD) cells (Abstract). J Am Soc Nephrol 1: 416, 1990.
17. Habibullah AA, Villarreal D, Freeman RH, Dietz JR, Vesely DL, and Simmons JC. Atrial natriuretic peptide fragments in dogs with experimental heart failure. Clin Exp Pharmacol Physiol 22: 130-135, 1995.
18. Hirth C, Stasch JP, John A, Kazda S, Morich F, Neuser D, and Wohlfeil S. The renal response to acute hypervolemia is caused by atrial natriuretic peptides. J Cardiovasc Pharmacol 8: 268-275, 1986.
19. Hirth C, Stasch JP, Kazda S, John A, Morich F, Neuser D, and Wohlfeil S. Blockade of the response to volume expansion by monoclonal antibodies against atrial natriuretic peptides. Klin Wochenschr 65: 87-91, 1987.
20. John SWM, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, Flynn TG, and Smithies O. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267: 679-681, 1995.
21. Klinger JR, Warburton RR, Pietras LA, Swift R, John S, and Hill NS. Exaggerated pulmonary hypertensive responses during chronic hypoxia in mice with gene-targeted reductions in atrial natriuretic peptide. Chest 114: 79S-80S, 1998.
22. Lang RE, Thölken H, Ganten D, Luft FC, Ruskoaho H, and Unger T. Atrial natriuretic factor-a circulating hormone stimulated by volume loading. Nature 314: 264-266, 1985.
23. Lin K-F, Chao J, and Chao L. Atrial natriuretic peptide gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in salt-sensitive rats. Hum Gene Ther 9: 1429-1438, 1998.
24. 2-terminus are natriuretic and/or kaliuretic. Am J Physiol Renal Fluid Electrolyte Physiol 258: F1401-F1408, 1990.
25. Pamnani MB, Mueller GP, Ghai RD, and Haddy FJ. Role of atrial natriuretic factor in regulation of blood pressure in normotensive rats having reduced renal mass. Proc Soc Exp Biol Med 189: 297-303, 1988.
26. Ramirez G, Saba SR, Dietz JR, and Vesely DL. Immunocytochemical localization of proANF 1-30, proANF 31-67, and atrial natriuretic factor on the kidney. Kidney Int 41: 334-341, 1992.
27. Ruskoaho H. Atrial natriuretic peptide: synthesis, release and metabolism. Pharmacol Rev 44: 479-602, 1992.
28. Sarzaani R, Dessi-Fulgheri P, Salvi F, Serenelli M, Spagnolo D, Cola G, Pupita M, Giantomassi L, and Rappelli A. A novel promoter variant of the natriuretic peptide clearance receptor gene is associated with lower atrial natriuretic peptide and higher blood pressure in obese hypertensives. J Hypertens 17: 1301-1305, 1999.
29. Vesely DL, Douglass MA, Dietz JR, Gower WR, McCormick MT, Rodriguez-Paz G, and Schocken DD. Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce diuresis, natriuresis, and/or kaliuresis in humans. Circulation 90: 1129-1140, 1994.
30. Weir ML, Honrath U, Flynn TG, and Sonnenberg H. Lack of biological activity or specific binding of amino-terminal pro-ANP segments on the rat. Regul Pept 53: 111-122, 1994.
31. Winters CJ, Sallman AL, Baker BJ, Meadows J, Rico DM, and Vesely DL. The N-terminus and a 4,000-MW peptide from the midportion of the N-terminus of the atrial natriuretic factor prohormone each circulate in humans and increase in congestive heart failure. Circulation 80: 438-449, 1989.